SOLIGENIX, INC. Increase (Decrease) in Security Deposits
SOLIGENIX, INC. (SNGX) reported Increase (Decrease) in Security Deposits of -$20 for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInSecurityDeposits · last filed 2022-03-29
- SOLIGENIX, INC. increase (decrease) in security deposits for fiscal 2020 was -$20.00.
- SOLIGENIX, INC. increase (decrease) in security deposits for fiscal 2019 was -$23.00.
- SOLIGENIX, INC. increase (decrease) in security deposits for fiscal 2017 was -$22.73K.
| Period end | Increase (Decrease) in Security Deposits 12 month |
|---|---|
| 2020-12-31 | -$20.00 10-K · filed 2022-03-29 |
| 2019-12-31 | -$23.00 10-K · filed 2021-03-30 |
| 2017-12-31 | -$22.73K 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |